Westwood Holdings Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Westwood Holdings Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-576,673	Closed	-$10.8M	–	499
2022 Q1	$10.8M	Buy	576,673 +519,946	+917%	+$9.36M	0.1%	193
2021 Q4	$1.21M	Buy	+56,727	New	+$1.12M	0.01%	336

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Westwood Holdings Group's OCDX Position: Q2 2022 in Review

Westwood Holdings Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 576,673 shares — an estimated $10.8M sold.

Westwood Holdings Group first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $10.8M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Westwood Holdings Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Westwood Holdings Group sold 576,673 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $10.8M.
Westwood Holdings Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
Westwood Holdings Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $10.8M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Westwood Holdings Group's 13F filing for Q2 2022, filed 15 Aug 2022.